Status:

COMPLETED

Easing Psychosocial Burden for Informal Caregivers

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Glioblastoma

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

The overall goal of this study is to determine the best time to offer Meaning-Centered Psychotherapy (MCP), an intervention that has proven to be helpful in improving spiritual well-being and decreasi...

Eligibility Criteria

Inclusion

  • Part I Focus group GBM informal caregivers (ICs):
  • English-speaking as English proficiency screener and in the best judgment of the consenting professional. This is due to the focus groups being managed in English and the use of certain validated questionnaires only being available in English.
  • Age \> 18
  • IC to an MSKCC patient with GBM who died a year or more ago
  • Part II Randomized Intervention of GBM ICs:
  • English-speaking as per English proficiency screener and in the best judgment of the consenting professional
  • Current ICs to a patient with GBM
  • Age ≥ 18
  • Score of \> 4 on the Distress Thermometer (DT) and indication that this distress is related in some way to the caregiving role per self-report

Exclusion

  • In the judgment of the consenting professional, clinician or PI and/or as per medical record, severe psychopathology or cognitive impairment likely to interfere with the participation or completion of the protocol or ability to provide meaningful information
  • Another family member of caregiver to the same patients is currently enrolled in the study
  • Ultimately, if interested, all caregivers who decline participation or are ineligible for the study for any reason, including because another caregiver of the patient is currently enrolled in the study, will be offered referrals to the MSKCC Counseling Center and to local mental health providers

Key Trial Info

Start Date :

February 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 26 2024

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT03454295

Start Date

February 12 2018

End Date

March 26 2024

Last Update

April 1 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Memorial Sloan Kettering Commack (Consent only)

Commack, New York, United States, 11725

2

Memorial Sloan Kettering Westchester (Consent only)

Harrison, New York, United States, 10604

3

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10021